ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) (IIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02728752
Recruitment Status : Active, not recruiting
First Posted : April 5, 2016
Last Update Posted : January 9, 2019
Sponsor:
Information provided by (Responsible Party):
Octapharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 2019
  Estimated Study Completion Date : March 2019